As suggested by the reviewers, we performed sensitivity analyses by excluding the comparison of MRA + SGLT2i vs GLP-1 RA, which was responsible to the significant heterogeneity and inconsistency for the primary composite endpoint and hospitalizations for heart failure. The gene discussed is GLP1R; the disease is heart failure.